Having shown that ATP8B3, FOXR2, FRG2 and HIST1H4A KOs increased paclitaxel resistance and cancer stemness in vitro, we next investigated whether these KOs could also regulate paclitaxel effects in vivo. Here, FOXR2 is linked to cancer.